Paragon Advisors LLC Invests $1.83 Million in Astera Labs, Inc. $ALAB

Paragon Advisors LLC bought a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 9,342 shares of the company’s stock, valued at approximately $1,829,000.

Other large investors also recently modified their holdings of the company. Vanguard Group Inc. raised its stake in shares of Astera Labs by 29.6% during the 2nd quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock worth $1,089,491,000 after purchasing an additional 2,751,747 shares in the last quarter. State Street Corp raised its holdings in Astera Labs by 39.3% in the 2nd quarter. State Street Corp now owns 2,143,459 shares of the company’s stock valued at $193,812,000 after acquiring an additional 604,363 shares in the last quarter. 1832 Asset Management L.P. lifted its position in shares of Astera Labs by 151.4% during the 2nd quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock valued at $139,563,000 after acquiring an additional 929,600 shares during the period. Massachusetts Financial Services Co. MA increased its position in shares of Astera Labs by 46.6% in the third quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company’s stock worth $295,203,000 after purchasing an additional 479,360 shares during the period. Finally, Geode Capital Management LLC lifted its position in Astera Labs by 36.2% during the second quarter. Geode Capital Management LLC now owns 1,244,978 shares of the company’s stock worth $112,562,000 after purchasing an additional 330,841 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Stock Down 1.8%

ALAB stock opened at $167.90 on Thursday. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90. The stock’s 50 day moving average is $163.38 and its 200-day moving average is $170.80. The firm has a market capitalization of $28.36 billion, a PE ratio of 151.26, a P/E/G ratio of 2.33 and a beta of 1.50.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The company had revenue of $230.58 million for the quarter, compared to analysts’ expectations of $206.42 million. During the same period in the previous year, the business posted $0.23 EPS. The business’s revenue for the quarter was up 103.9% compared to the same quarter last year. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, equities research analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, COO Sanjay Gajendra sold 90,459 shares of Astera Labs stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the transaction, the chief operating officer owned 1,599,750 shares in the company, valued at $231,467,827.50. This trade represents a 5.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jitendra Mohan sold 90,459 shares of the firm’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the transaction, the chief executive officer owned 2,080,418 shares in the company, valued at approximately $301,015,680.42. The trade was a 4.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 576,936 shares of company stock worth $87,409,540. 12.50% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research analysts have commented on ALAB shares. JPMorgan Chase & Co. boosted their price objective on shares of Astera Labs from $180.00 to $215.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. Wall Street Zen lowered Astera Labs from a “buy” rating to a “hold” rating in a research report on Tuesday, November 11th. Morgan Stanley reiterated an “overweight” rating and set a $210.00 target price on shares of Astera Labs in a research report on Wednesday, December 3rd. Northland Securities upped their price target on shares of Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a research report on Tuesday, December 9th. Finally, Jefferies Financial Group reiterated a “buy” rating on shares of Astera Labs in a report on Wednesday, December 3rd. Fifteen research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $190.63.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.